Xamoterol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (RS)-N-(2-{[2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino}ethyl)morpholine-4-carboxamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 81801-12-9 |
| ATC code | C01CX07 |
| PubChem | CID 155774 |
| IUPHAR ligand | 538 |
| ChemSpider | 137213 |
| UNII | 7HE0JQL703 |
| KEGG | D06328 |
| ChEMBL | CHEMBL75753 |
| Chemical data | |
| Formula | C16H25N3O5 |
| Mol. mass | 339.387 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Xamoterol is a cardiac stimulant. It works by binding to the β1 adrenergic receptor. it is a 3rd generation andrenergics beta receptor partial agonist. it provides cardiac stimulation when patient is at rest but it acts as a blocker during exercise. [1]
[edit] References
- ^ Rang, H. P. (2003). Pharmacology. Edinburgh: Churchill Livingstone. ISBN 0-443-07145-4. Page 163
|
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |

